iShares Trust - iShares Biotechnology ETF
US ˙ NasdaqGM ˙ US4642875565

SecurityIBB / iShares Trust - iShares Biotechnology ETF
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership684 shares
Latest Disclosed Value $ 115,540
Parallel Advisors, LLC ownership in IBB / iShares Trust - iShares Biotechnology ETF

On February 11, 2026 - Parallel Advisors, LLC filed a 13F-HR form disclosing ownership of 684 shares of iShares Trust - iShares Biotechnology ETF (US:IBB) valued at $115,439 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 834 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -17.99% during the quarter. The current value of the position is $114,570 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (IBB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IBB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 684 -150 -17.99 116 -4.17 0.0021
2025-11-13 2025-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 834 -300 -26.46 120 -16.08 0.0022
2025-07-08 2025-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 1,134 -1 -0.09 143 -1.38 0.0029
2025-04-08 2025-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 1,135 -104 -8.39 145 -11.04 0.0033
2025-02-10 2024-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 1,239 -135 -9.83 164 -18.50 0.0037
2024-11-13 2024-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 1,374 0 0.00 200 6.38 0.0047
2024-08-08 2024-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 1,374 -574 -29.47 189 -29.59 0.0048
2024-05-06 2024-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 1,948 -2,670 -57.82 267 -57.42 0.0072
2024-02-12 2023-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,618 -783 -14.50 627 -5.00 0.0186
2024-05-20 2023-09-30 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,401 -675 -11.11 661 -14.40 0.0220
2023-11-14 2023-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,401 -675 661 0.0220
2024-05-20 2023-06-30 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,076 -153 -2.46 772 -4.10 0.0248
2023-08-04 2023-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,076 -153 772 0.0248
2024-05-20 2023-03-31 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,229 1,686 37.11 805 34.90 0.0271
2023-04-25 2023-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,229 1,686 805 0.0271
2023-02-06 2022-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,543 178 4.08 597 16.63 0.0259
2022-11-10 2022-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,365 218 5.26 511 4.71 0.0235
2022-08-01 2022-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,147 190 4.80 488 -5.79 0.0224
2022-04-28 2022-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,957 -324 -7.57 518 -20.67 0.0206
2022-01-20 2021-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,281 -48 -1.11 653 -6.71 0.0242
2021-11-02 2021-09-30 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,329 -31 -0.71 700 -1.96 0.0282
2021-08-06 2021-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,360 0 0.00 714 8.84 0.0302
2021-04-23 2021-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,360 122 2.88 656 2.18 0.0310
2021-02-02 2020-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,238 -23 -0.54 642 11.27 0.0348
2020-10-27 2020-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,261 -549 -11.41 577 -12.18 0.0357
2020-07-16 2020-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 4,810 1,159 31.74 657 67.18 0.0429
2020-04-27 2020-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,651 -75 -2.01 393 -12.47 0.0318
2020-01-30 2019-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,726 554 17.47 449 42.09 0.0337
2019-11-01 2019-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,172 0 0.00 316 -8.67 0.0271
2019-08-05 2019-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,172 -383 -10.77 346 -12.85 0.0338
2019-05-01 2019-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,555 -144 -3.89 397 11.52 0.0446
2019-02-05 2018-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,699 204 5.84 356 -16.43 0.0496
2018-11-01 2018-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,495 111 3.28 426 14.82 0.0529
2018-07-30 2018-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,384 0 0.00 371 2.77 0.0530
2018-05-08 2018-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 3,384 0 0.00 361 0.00 0.0564
2018-02-13 2017-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 3,384 2,256 200.00 361 3.14 0.0591
2017-11-15 2017-09-30 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 1,128 20 1.81 350 -1.13 0.0602
2017-11-14 2017-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY COM 464287556 5,603 4,495 1,869 3.0905
2017-08-07 2017-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 1,108 0 0.00 354 7.93 0.0668
2017-05-12 2017-03-31 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 1,108 -225 -16.88 328 -7.34 0.0652
2017-05-12 2017-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 1,108 328
2017-02-14 2016-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 1,333 1,333 354 0.0831
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Call 4,360 714 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.